Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2017
Designing an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth InhibitionPavan P Adiseshaiah, Stephan T Stern
The AAPS Journal|October 12, 2017
Nanotechnology as a Delivery Tool for Precision Cancer TherapiesBhawna Sharma, Rachael M Crist, Pavan P Adiseshaiah
Particle and Fibre Toxicology|June 16, 2012
Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicityStephan T Stern, Pavan P Adiseshaiah, Rachael M Crist
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|January 6, 2010
Nanomaterial standards for efficacy and toxicity assessmentPavan P Adiseshaiah, Jennifer B Hall, Scott E McNeil
Nature Reviews. Clinical Oncology|August 18, 2016
Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancerPavan P Adiseshaiah, Rachael M Crist, Sara S Hook, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2017
Assessing NLRP3 Inflammasome Activation by NanoparticlesBhawna Sharma, Christopher B McLeland, Timothy M Potter, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2017
Autophagy Monitoring Assay II: Imaging Autophagy Induction in LLC-PK1 Cells Using GFP-LC3 Protein Fusion ConstructPavan P Adiseshaiah, Sarah L Skoczen, Jamie C Rodriguez, et al.
International Journal of Molecular Imaging|April 12, 2014
Longitudinal imaging of cancer cell metastases in two preclinical models: a correlation of noninvasive imaging to histopathologyPavan P Adiseshaiah, Nimit L Patel, Lilia V Ileva, et al.
Cancer Research|January 9, 2020
Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic CancersSuman Mukhopadhyay, Debanjan Goswami, Pavan P Adiseshaiah, et al.
Pageof 2